Prognostic implication of ezrin overexpression in myxofibrosarcomas

Annals of Surgical Oncology

Volumn 17, Issue 12, 2010, Pages 3212-3219

  Huang, Hsuan Ying ^a   Li, Chien Feng ^b,c   Fang, Fu Min ^a   Tsai, Jen Wei ^d   Li, Shau Hsuan ^a   Lee, Yuan Ting ^a   Wei, Huei Min ^c  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^d E DA HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EZRIN; MESSENGER RNA;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FIBROMYXOSARCOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOMA; SARCOMA CELL; TISSUE MICROARRAY; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CELLS, CULTURED; CYTOSKELETAL PROTEINS; FEMALE; FIBROBLASTS; FIBROSARCOMA; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; MYXOSARCOMA; NEOPLASM STAGING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; YOUNG ADULT;

EID: 78650968656     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1185-y     Document Type: Article

References (23)

1. T Mentzel E Calonje C Wadden 1996 Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant Am J Surg Pathol 20 391 405 1:STN:280:DyaK287otlertQ%3D%3D 10.1097/00000478-199604000-00001 8604805 (Pubitemid 26113344)
2. HY Huang P Lal J Qin MF Brennan CR Antonescu 2004 Low-grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems Hum Pathol 35 612 621 10.1016/j.humpath.2004.01.016 15138937 (Pubitemid 38656947)
3. CN Lin SC Chou CF Li, et al. 2006 Prognostic factors of myxofibrosarcomas: implications of margin status, tumor necrosis, and mitotic rate on survival J Surg Oncol 93 294 303 10.1002/jso.20425 16496357
4. A Bretscher K Edwards RG Fehon 2002 ERM proteins and merlin: integrators at the cell cortex Nat Rev Mol Cell Biol 3 586 599 1:CAS:528: DC%2BD38XlslGrtbc%3D 10.1038/nrm882 12154370
5. DT Dransfield AJ Bradford J Smith, et al. 1997 Ezrin is a cyclic AMP-dependent protein kinase anchoring protein EMBO J 16 35 43 1:CAS:528:DyaK2sXotFahtg%3D%3D 10.1093/emboj/16.1.35 9009265 (Pubitemid 27032847)
6. KW Hunter 2004 Ezrin, a key component in tumor metastasis Trends Mol Med 10 201 204 1:CAS:528:DC%2BD2cXjs1Wgtb8%3D 10.1016/j.molmed.2004.03.001 15121044 (Pubitemid 38581790)
7. B Bruce G Khanna L Ren, et al. 2007 Expression of the cytoskeleton linker protein ezrin in human cancers Clin Exp Metastasis 24 69 78 1:CAS:528:DC%2BD2sXmt1Cqsbs%3D 10.1007/s10585-006-9050-x 17370041 (Pubitemid 46669242)
8. KD Geiger P Stoldt W Schlote A Derouiche 2000 Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas Am J Pathol 157 1785 1793 1:CAS:528:DC%2BD3MXhsVKktQ%3D%3D 11106550
9. C Khanna X Wan S Bose, et al. 2004 The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis Nat Med 10 182 186 1:CAS:528:DC%2BD2cXoslKmsw%3D%3D 10.1038/nm982 14704791 (Pubitemid 38524889)
10. Y Yu J Khan C Khanna, et al. 2004 Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators Nat Med 10 175 181 1:CAS:528:DC%2BD2cXoslKntQ%3D%3D 10.1038/nm966 14704789 (Pubitemid 38524888)
11. TA Martin G Harrison RE Mansel WG Jiang 2003 The role of the CD44/ezrin complex in cancer metastasis Crit Rev Oncol Hematol 46 165 186 10.1016/S1040-8428(02)00172-5 12711360 (Pubitemid 36452345)
12. HY Huang WW Huang JM Wu, et al. 2008 Flow cytometric analysis of DNA ploidy and S-phase fraction in primary localized myxofibrosarcoma: correlations with clinicopathological factors, Skp2 expression, and patient survival Ann Surg Oncol 15 2239 2249 10.1245/s10434-008-9968-0 18516647
13. HY Huang HY Kang CF Li, et al. 2006 Skp2 overexpression is highly representative of intrinsic biological aggressiveness and independently associated with poor prognosis in primary localized myxofibrosarcomas Clin Cancer Res 12 487 498 1:CAS:528:DC%2BD28XmtlKitQ%3D%3D 10.1158/1078-0432.CCR-05- 1497 16428491 (Pubitemid 43166140)
14. L Guillou JM Coindre F Bonichon, et al. 1997 Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma J Clin Oncol 15 350 362 1:STN:280:DyaK2s7kvFemtg%3D%3D 8996162
15. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M. Soft tissue sarcoma. In: American Joint Committee on Cancer Staging Manual. 6th ed. New York: Springer-Verlag; 2002. p. 193-200.
16. YC Wei CF Li SC Yu, et al. 2009 Ezrin overexpression in gastrointestinal stromal tumors: an independent adverse prognosticator associated with the non-gastric location Mod Pathol 22 1351 1360 1:CAS:528:DC%2BD1MXhtF2ltb3F 10.1038/modpathol.2009.107 19648886
17. AK Krause SH Hinrichs C Orndal, et al. 1997 Characterization of a human myxoid malignant fibrous histiocytoma cell line, OH931 Cancer Genet Cytogenet 94 138 143 1:STN:280:DyaK2s3msVSksA%3D%3D 10.1016/S0165-4608(96)00223-3 9109944 (Pubitemid 27169348)
18. H Kawashima A Ogose W Gu, et al. 2005 Cancer Genet Cytogenet 161 28 35 1:CAS:528:DC%2BD2MXntVCrt70%3D 10.1016/j.cancergencyto.2005.02.003 16080955 (Pubitemid 41096048)
19. J Moilanen H Lassus A Leminen, et al. 2003 Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients Gynecol Oncol 90 273 281 1:CAS:528:DC%2BD3sXlvVCqs7w%3D 10.1016/S0090-8258(03)00262-2 12893187 (Pubitemid 36952014)
20. SE ten Heuvel HJ Hoekstra E Bastiaannet AJ Suurmeijer 2009 The classic prognostic factors tumor stage, tumor size, and tumor grade are the strongest predictors of outcome in synovial sarcoma: no role for SSX fusion type or ezrin expression Appl Immunohistochem Mol Morphol 17 189 195 1:CAS:528: DC%2BD1MXkvVWmsrw%3D 10.1097/PAI.0b013e31818a6f5c 18997619
21. G Wang W Mao S Zheng 2008 MicroRNA-183 regulates Ezrin expression in lung cancer cells FEBS Lett 582 3663 3668 1:CAS:528:DC%2BD1cXht12rt7%2FF 10.1016/j.febslet.2008.09.051 18840437
22. X Wan SY Kim LM Guenther, et al. 2009 Beta4 integrin promotes osteosarcoma metastasis and interacts with ezrin Oncogene 28 3401 3411 1:CAS:528:DC%2BD1MXosFWhtr4%3D 10.1038/onc.2009.206 19597468
23. T Crepaldi A Gautreau PM Comoglio D Louvard M Arpin 1997 Ezrin is an effector of hepatocyte growth factor-mediated migration and morphogenesis in epithelial cells J Cell Biol 138 423 434 1:CAS:528:DyaK2sXkvFCjsrs%3D 10.1083/jcb.138.2.423 9230083 (Pubitemid 27323543)